SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 42 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,398,913 | -25.6% | 6,095,675 | -0.1% | 0.00% | – |
| Q2 2023 | $15,312,231 | +497.2% | 6,100,490 | +316.4% | 0.00% | – |
| Q1 2023 | $2,563,976 | -58.2% | 1,465,129 | +1.5% | 0.00% | – |
| Q4 2022 | $6,135,121 | +564.7% | 1,443,558 | +86.0% | 0.00% | – |
| Q3 2022 | $923,000 | +18.9% | 775,922 | 0.0% | 0.00% | – |
| Q2 2022 | $776,000 | -65.2% | 775,922 | -14.9% | 0.00% | – |
| Q1 2022 | $2,233,000 | -8.5% | 911,396 | +0.5% | 0.00% | – |
| Q4 2021 | $2,440,000 | -46.2% | 906,887 | +0.1% | 0.00% | – |
| Q3 2021 | $4,537,000 | -30.9% | 905,530 | +2.9% | 0.00% | – |
| Q2 2021 | $6,564,000 | +103.5% | 879,898 | +60.1% | 0.00% | – |
| Q1 2021 | $3,226,000 | +24.9% | 549,542 | 0.0% | 0.00% | – |
| Q4 2020 | $2,583,000 | – | 549,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polar Capital Holdings Plc | 5,800,000 | $27,260,000 | 0.16% |
| Inscription Capital, LLC | 17,000 | $80,000 | 0.03% |
| ExodusPoint Capital Management, LP | 185,844 | $873,000 | 0.01% |
| HoyleCohen, LLC | 10,359 | $49,000 | 0.01% |
| Virtu Financial LLC | 10,835 | $51,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,783 | $18,000 | 0.00% |
| Renaissance Technologies | 253,212 | $1,190,000 | 0.00% |
| Baillie Gifford | 372,261 | $1,749,000 | 0.00% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 37,238 | $175,000 | 0.00% |
| BREWIN DOLPHIN LTD | 1,970 | $9,259 | 0.00% |